Optibiotix Health Share Discussion Threads

[1bokke] 10/1/2019 11:44

Couldn't touch it with the proverbial because your ukog shares are now worth 3 smarties and a button.

[rayrac] 10/1/2019 11:34

Wouldn’t touch it with the proverbial.

[diamond fibre] 10/1/2019 11:23

[WE ARE] .Rayrac, so if you hold shares in Optibiotix why do you keep knocking them? you just like winding people up. DIAMOND.

[m4rtinu] 10/1/2019 10:31

Risky - I may be being a bit pedantic, but do you think Operational Costs might be nearer 200k a month than 100k now? However, I agree on your general point about break even on month-to-month basis now (as stated by SOH) and probably showing profit by end of FY 19 (my assumption). Just don't want other posters to be shocked by the upcoming FY 18 results, which will still show an Operational Loss.

[rayrac] 10/1/2019 10:22

Volumes need picking up, we are trading minimal amounts even with news.

And mainly sells! Someone’s not happy.

[rayrac] 10/1/2019 10:08

Funny you should mention lemmings slartyfartfaster! Collar and lead on today have we?!

There’s a good boy.:)

[grandmasterglitch] 10/1/2019 09:53

Good post risky, however I’d say this is as volatile as it gets as a share, it’s up and down with little stability. Look at likes of BMN, that’s power of punters arriving on mass.

Get a uk supermarket deal, herds arrive we will have a more stable share price imho.

Volumes need picking up, we are trading minimal amounts even with news.

[riskybusiness1] 10/1/2019 09:49

Partners with Jannssen from their site https://www.janssen.com/uk/ 'One of the world's leading research-based pharmaceutical companies and part of the Johnson & Johnson family of companies – the largest diversified healthcare group in the world.'Wonder what J & J are partnered with Silvexpo for, probably because there's no money to be made out in Russia, Bulgaria etc like you said Dazah? Idiot

[riskybusiness1] 10/1/2019 09:41

I agree we need II but it's difficult for them to take a significant stake on these volumes. Their only way of building a stake is through a placement or buying from existing holders wishing to offload eg Yorkshire.Dazah they're selling Cholbiome to s compsny thst distributes products in a lot of Eastern European countries. A sale is a sale at the end of the day. Silvxpo are a well established Latvian company who are partnered with Jannssen so they'll probably sell a fair few. They also seem to be well linked to pharmacy's and appear to have a great track record of finding revolutionary new science...

[trotterstrading] 10/1/2019 09:38

Daz with (diminishing) respect you have been here 5 mins, you know Jack about SoH or the Company strategy- which has been clear since day one, you also openly admit your a trader, anyone fool enough to take anything you say seriously is risking a life changing return on this share over the course of the next few years. You may turn up your nose at some of these territories but the fact is they are all adding incremental revenue at ZERO cost to OPTI. This approach continues to derisk the business and put OPTI in the driving seat while negotiating with the Majors (not an easy task) to many AIM flash in the pan Co's stake their future on a single deal mitt major corporates only to be one slaves to their will. Our approach is entirely the RIGHT way to build a sustainable business, enabling us to CHOSE partners who offer the best terms. This may not be as quick as we would like but it will undoubtedly yield the best returns over the medium to long term

[siennadelekat21] 10/1/2019 09:32

Dazah, you confess to being a trader, yet somehow you're allergic to volatility in the share price? You should be loving these opportunities to trade - how have you got time to moan when you should be taking advantage of these trading opportunities?Sienna

[imnotlong] 10/1/2019 09:29

Another good post Risky. I think a big part of the problem is that the average Joe so far has never heard of Optibiotix or its products. That and the fact that no new II have taken a declared stake so the share price is still massively effected by traders.

There must be reasons that II’s have not bought into the compelling investment opportunity you describe. Lots of funds do invest at this stage of a companies development.

[dazah] 10/1/2019 09:26

Speccy, I got 6 thumbs up so there are some posters on here appreciate my writings. I've got no agenda just because sometimes I point out some themes in numerous RNSs. And even in your last post your comments regarding revenue are purely conjecture just like mine are so we are both writing with a viewpoint and conjecture because that revenue you talk about may not transpire because the deal may not transpire. Just like revenue may not also transpire from Russia which has a very poor population and its probably the poor that are obease and therefore can't afford £14 for 8 muesli pots or whatever is being sold. Same goes for Bulgaria etc.

[riskybusiness1] 10/1/2019 09:06

Marc SOH has told us through multiple interviews now that In H2 we were BE on a month to month basis, going on previous statements that's exactly what will show IMO £400-£500k revenue which is 5x6x increase on H1. £100k operational costs per month so you can see if they started rolling in the cash in the later stages of H2 then it's easily BE like he said.We obviously want the share price to rise but having them in the form of spikes resulting from a deal with a retailer where average joe understands imo would significantly increase volatility. Once revenues start showing through and it becomes apparent we don't need to sell as much in contrast to a supermarket deal to become significantly profitable due to the model, we should begin sustainable rise an healthy pullbacks. Don't get me wrong I think a supermarket deal will be great for volumes and market presence within the U.K. and I'm certain they will come but to knock current deals over a supermarket deal in the UK is not particularly wise.I'm sure average Joe can figure out products entering markets all over the world at virtually zero costs will be far more profitable than a U.K. supermarket deal. US pharma deal, TATA deal, Sweetbiotix dairy deal with multi bn company, 100bn turnover company paying 6 figures for exclusive negotiations and companies like Alfa Sigma one of the biggest pharmaceutical companies in Italy the biggest market in Europe for these products signing a ten year contract. These are the biggies + I'm probably missed a few. Quick point on Alfa Sigma, Sigma Tau as they were called before they merged with Alfa have a probiotic they license from VSL pharmaceuticals called VSL which sells upwards of £40m+ and is one of the top selling probiotics worldwide. They will take a while to launch because they will go very big with LPLDL but once they do the cash rolls in very fast.

[speccy1] 10/1/2019 08:56

Right. That's the final straw. I've put up with his inane gibbering for long enough. Dazah is now filtered.

50% of nothing he moans. For goodness sake, do you have the remotest idea how many people live in India and Russia.

You either have a sinister agenda or you're as thick as a plank, but I can't suffer your idiocy any longer

[1bokke] 10/1/2019 08:30

Personally I'm hoping the next announcement is on this thread and that it says Dazah has decided to take his cash and put it in a savings account where growth is nice and predictable..